STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

TAK TAKEDA PHARMACEUTICAL COMPANY LIMITED StockScouter® Report

5

StockScouter® Score

TAKEDA PHARMACEUTICAL COMPANY LIMITED, a large cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The ratio of TAK’s forward price-to-earnings multiple to its estimated growth rate is well below the average of comparably-sized companies in the StockScouter universe. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 40% done.
Low
High

Core Model Grades

F
C
N/A
F

Previous Ratings

6
5